EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:750086 |
| ChEBI Name | daratumumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Applications: | anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. anti-inflammatory agent Any compound that has anti-inflammatory effects. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| daratumumab (CHEBI:750086) has role anti-anaemic agent (CHEBI:75835) |
| daratumumab (CHEBI:750086) has role anti-inflammatory agent (CHEBI:67079) |
| daratumumab (CHEBI:750086) has role antineoplastic agent (CHEBI:35610) |
| daratumumab (CHEBI:750086) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| 3003-005 | ChEMBL |
| Daratumumab | ChEMBL |
| Daratumumab-fihj | ChEMBL |
| Darzalex | ChEMBL |
| HuMax-CD38 | ChEMBL |
| HUMAX-CD 38 | ChEMBL |
| Brand Name | Source |
|---|---|
| Daratumumab component of darzalex faspro | ChEMBL |